Theory Financial’s Eli Lilly LLY Stock Holding History

Theory Financial’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$300K	Buy	326 +79	+32%	+$80.1K	0.11%	83
2025 Q4	$262K	Sell	247 -8	-3%	-$7.65K	0.09%	91
2025 Q3	$206K	Buy	+255	New	+$190K	0.07%	90
2025 Q2	–	Sell	-280	Closed	-$231K	–	92
2025 Q1	$231K	Buy	+280	New	+$233K	0.1%	74
2023 Q4	–	Sell	-1,715	Closed	-$921K	–	73
2023 Q3	$921K	Sell	1,715 -121	-7%	-$62.4K	0.54%	38
2023 Q2	$861K	Hold	1,836	–	–	0.5%	38
2023 Q1	$631K	Hold	1,836	–	–	0.38%	43
2022 Q4	$672K	Buy	+1,836	New	+$651K	0.44%	41

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Theory Financial's LLY Position: Q1 2026 in Review

Theory Financial increased its Eli Lilly (LLY) stake by 32% in Q1 2026, buying an estimated $80.1K and bringing the position to 326 shares worth $300K. The position accounts for 0.11% of the portfolio, ranked #83.

Theory Financial first reported a position in LLY in Q4 2022 and has held it in 8 quarters since. The position peaked at $921K in Q3 2023. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Theory Financial held 326 shares of Eli Lilly worth $300K as of Q1 2026.
Theory Financial bought 79 Eli Lilly shares in Q1 2026, an estimated $80.1K.
Eli Lilly made up 0.11% of Theory Financial's portfolio in Q1 2026, its #83 holding.
Theory Financial first reported a position in Eli Lilly in Q4 2022 and has held it in 8 quarters since.
Theory Financial's Eli Lilly position peaked at $921K in Q3 2023.
4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Theory Financial's 13F filing for Q1 2026, filed 5 May 2026.